B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SAE1

MOLECULAR TARGET

SUMO1 activating enzyme subunit 1

UniProt: Q9UBE0NCBI Gene: 100559 compounds

SAE1 (SUMO1 activating enzyme subunit 1) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SAE1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1DEAD-box RNA Helicases1.102
2Thioctic Acid1.102
3Thioctic Acid1.102
4Rosmarinic Acid0.691
5Demeclocycline0.691
6Edaravone0.691
7Hexachlorophene0.691
8Methyldopa0.691
9rafoxanide0.691

About SAE1 as a Drug Target

SAE1 (SUMO1 activating enzyme subunit 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented SAE1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SAE1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.